As of November 6, 2026, OSR Health, Inc. has Schedule 13D or 13G filings on record, none whose latest reports a stake of 5% or more. 2 filings are on record since April 22, 2026 (Schedule 13G/A, August 17, 2026).
Sell to companies like OSR Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
OSR Health, Inc. has 2 Schedule 13D or 13G filings on record since 2026-04-22. No holder's latest filing reports 5% or more. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| joint protein central inc. | 3.4% | 1,200,000 | SCHEDULE 13G/A, 2026-08-17 | 2026-06-24 |
Holding shares or following this stake? See who's behind OSR Health, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on OSR Health, Inc. and the records around it.
OSR Health, Inc. elsewhere on the record
Watch OSR Health, Inc.
Get an email when OSR Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on OSR Health, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on OSR Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on OSR Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| joint protein central inc. | 1,200,000 | 0 | 1,200,000 | 0 | SCHEDULE 13G/A, 2026-08-17 |
The latest filing identifies OSR Health, Inc. by CUSIP 68840D102 and gives its principal executive office as 10900 NE 4TH STREET, SUITE 2300, BELLEVUE, WA 98004 (SCHEDULE 13G/A, 2026-08-17).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-04-22 | joint protein central inc. | 7.9% | SCHEDULE 13G |
| 2026-08-17 | joint protein central inc. | 3.4% | SCHEDULE 13G/A |
Also on the record for OSR Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 2, 2026 | Leadership change: Constance Hoefer departs, Chief Scientific Officer | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for OSR Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.